Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer-Reference-Cited by-同舟云学术

Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

Published:2019-04-15 Issue:2 Volume:51 Page:438-450
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Garona Juan,Sobol Natasha T.,Pifano Marina,Segatori Valeria I.,Gomez Daniel E.,Ripoll Giselle V.,Alonso Daniel F.

Funder

National Institute of Cancer

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2018-040.pdf

Reference30 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Antimetastatic effect of desmopressin in a mouse mammary tumor model

3. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

4. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP

5. Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal digestion of food proteins: Anticancer, antihypertensive, anti-obesity, and immunomodulatory mechanisms of the derived peptides;Food Research International;2024-08

2. Vasopressin Analog [V⁴Q⁵]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models;World Journal of Oncology;2023-12

3. Natural Peptide Toxins as an Option for Renewed Treatment of Type 2 Vasopressin Receptor-Related Diseases;Biology;2023-04-03

4. AVPR2 is a potential prognostic biomarker and correlated with immune infiltration in head and neck squamous cell carcinoma;BMC Medical Genomics;2023-03-30

5. Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy;Scientific Reports;2022-09-08